Trials / Sponsors / Biogenea Pharmaceuticals Ltd.
Biogenea Pharmaceuticals Ltd.
Industry · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer Endometrial Carcinoma, Endometrial Carcinoma Stage III | EARLY_Phase 1 | 2026-02-02 |
| Enrolling By Invitation | Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum- NSCLC (Non-small Cell Lung Cancer), Squamous Lung Cancer With FGFR1 Amplification, Non-Squamous Non Small Cell Lung Cancer | EARLY_Phase 1 | 2026-02-02 |
| Recruiting | COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer Colorectal Cancer Metastatic, Colorectal Cancer Stage III, Colorectal Cancer Stage IV | EARLY_Phase 1 | 2026-02-02 |
| Recruiting | Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine Glioma | EARLY_Phase 1 | 2025-07-01 |